Loading
Loading
Research Overview
Copper-binding tripeptide (alanine-histidine-lysine); activates dermal papilla cells in vitro via copper-dependent cellular signalling in the same copper-peptide class as GHK-Cu but with distinct amino acid flanking producing follicular-biology selectivity.
Overview
AHK-Cu is a copper-binding tripeptide comprising the amino acid sequence alanine-histidine-lysine, chelated to copper in the same chemical class as the better-characterised GHK-Cu (glycine-histidine-lysine copper). Like GHK-Cu, it utilises the histidine residue for copper coordination, but its different flanking amino acids produce a distinct biological activity profile with particular relevance to follicular biology.
In vitro research using dermal papilla cells has examined AHK-Cu's potential to activate the cellular populations responsible for hair follicle cycling and growth. Dermal papilla cells are the dermal signalling centres of hair follicles โ their activation is considered a research target for follicular support applications. Most AHK-Cu research involves topical application rather than systemic administration.
Evidence for AHK-Cu effects is limited primarily to in vitro cell culture studies and some topical formulation research. Unlike GHK-Cu, which has a broader research base spanning wound healing, skin remodelling, and anti-ageing applications, AHK-Cu's research literature is narrower and more specifically directed toward follicular biology.
Compliance
Sold strictly as a research chemical for non-human, in-vitro, and laboratory use
FDA approved compound
Prescription availability in Australia and internationally
In Australia, ahk-cu (copper tripeptide-2) has no TGA approval for therapeutic use. It is sold by Capital Peptides strictly as a research chemical for non-human, in-vitro, and laboratory research use only.
Pharmacology
Copper-binding tripeptide (alanine-histidine-lysine); activates dermal papilla cells in vitro via copper-dependent cellular signalling in the same copper-peptide class as GHK-Cu but with distinct amino acid flanking producing follicular-biology selectivity.
Support
Available from Capital Peptides
For research use only. Capital Peptides products are not approved by the TGA for therapeutic use. By purchasing you confirm you are a licensed research entity or qualified professional.